Purpose
To explore the role and molecular mechanisms of neuroprotective effects of
octreotide in alcohol-induced neuropathic pain.
Methods
Male Wistar rats were employed and were administered a chronic ethanol diet
containing 5% v/v alcohol for 28 days. The development of neuropathic pain
was assessed using von Frey hair (mechanical allodynia), pinprick
(mechanical hyperalgesia) and cold acetone drop tests (cold allodynia). The
antinociceptive effects of octreotide (20 and 40 µg·kg
–1
) were
assessed by its administration for 28 days in ethanol-treated rats. ANA-12
(0.25 and 0.50 mg·kg
–1
), brain-derived neurotrophic factor (BDNF)
receptor blocker, was coadministered with octreotide. The sciatic nerve was
isolated to assess the biochemical changes including hydrogen sulfide
(H
2
S), cystathionine β synthase (CBS), cystathionine γ lyase
(CSE), tumor necrosis factor-α (TNF-α), BDNF and nuclear factor erythroid
2-related factor 2 (Nrf2).
Results
Octreotide significantly attenuated chronic ethanol-induced neuropathic pain
and it also restored the levels of H
2
S, CBS, CSE, BDNF, Nrf2 and
decreased TNF-α levels. ANA-12 abolished the effects of octreotide on pain,
TNF-α, BDNF, Nrf2 without any significant effects on H
2
S, CBS,
CSE.
Conclusions
Octreotide may attenuate the behavioral manifestations of alcoholic
neuropathic pain, which may be due to an increase in H
2
S, CBS,
CSE, BDNF, Nrf2 and a decrease in neuroinflammation.